Picramnia antidesma
Picramnia antidesma · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Picramnia antidesma is a botanical species recognized for its significant therapeutic potential in traditional medicine. Researchers have identified that the plant's roots are particularly rich in bioactive anthraquinone derivatives. These specific chemical compounds are of great interest due to their efficacy in addressing conditions such as malaria. To harness these medicinal properties, various preparations including crude extracts and infusions are commonly utilized. Consequently, this plant serves as a vital subject in the study of natural antimalarial agents.
- Synonyms
- Tariri Antidesma
- Common names
- Not available
- Family
- Picramniaceae
- Distribution
- Not available
- Plant Parts
- Root
Classification
Common Names
Picramnia antidesma is a versatile plant known by several distinct regional names. In certain areas, it is commonly referred to as Caregre. It is also frequently identified by the name Chilillo. In other contexts, particularly within specific linguistic traditions, it is called pikramnia liečivá. These diverse common names reflect the plant's widespread presence across different cultures and geographies.
Sources: Catalogue of Life (COL)
Synonyms
Picramnia antidesma is a botanical species that is also recognized by the scientific synonym Tariri antidesma. This naming overlap often occurs in taxonomic literature as researchers refine the classification of various plant families. Understanding these synonymous relationships is crucial for botanists seeking to maintain accurate records of global biodiversity. By recognizing both terms, researchers can ensure that data regarding this plant remains consistent across different studies. Ultimately, these linguistic connections help bridge the gap between historical classifications and modern botanical science.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Picramnia antidesma is a distinctive botanical species belonging to the kingdom Plantae. Within this vast kingdom, it is classified under the class Equisetopsida. The plant is further organized into the order Picramniales, showcasing its specific evolutionary lineage. It falls under the family Picramniaceae, which defines its unique biological characteristics. Finally, its taxonomic identity is solidified by its placement within the genus Picramnia.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Picramniales |
| Family | Picramniaceae |
| Genus | Picramnia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Picramnia antidesma is a plant species with a notable presence throughout various regions of North America. Specifically, its distribution is heavily concentrated within Mexico, where it thrives across diverse geographical areas. The plant can be found spanning from the central territories to the expansive Gulf regions. Furthermore, its range extends into the northeast, northwest, and southeast portions of the country. This widespread coverage highlights the plant's adaptability to the varied climates found across the Mexican landscape.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Picramnia antidesma is characterized by its distinct growth form as a sturdy tree. As a self-supporting species, it maintains its structural integrity without the need for external assistance.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Compounds
Picramnia antidesma is a medicinal plant that has long been utilized in the tropical Americas for the treatment of malaria. Recent activity-guided investigations of its root bark have revealed a rich mixture of anthrone glycosides. Specifically, researchers identified that the plant contains potent anthraquinone derivatives capable of inducing cytotoxicity in KB cells. While these compounds demonstrate significant biological activity, their high levels of cytotoxicity pose challenges for therapeutic use. Consequently, the lack of a sufficient selectivity index suggests that infusions from this crude drug may not be effective as antimalarial agents.
Conditions
Picramnia antidesma has a long history of use as a medicinal plant for treating malaria in the tropical regions of the Americas. Researchers investigated its root bark to identify the specific compounds responsible for its traditional antimalarial properties. While the plant contains potent anthraquinone derivatives, these substances exhibit high levels of cytotoxicity when tested on cells. This intense toxicity means that infusions from the crude drug lack the necessary selectivity index to function as a safe and effective antimalarial agent. Consequently, the relationship between the plant's chemical makeup and its efficacy in treating malaria remains a complex pharmacological challenge.
Preparations
Picramnia antidesma is prepared as crude extracts from its root bark to facilitate activity-guided investigations into its medicinal properties. These crude extracts have been used to isolate new compounds, such as 10-epi-uveoside, from cytotoxic fractions. Additionally, Picramnia antidesma is prepared as infusions derived from this crude drug. However, research indicates that these infusions lack the necessary selectivity index to function as effective antimalarial agents. The study of these various preparations highlights the complex chemical profile of the plant's anthraquinone derivatives.
Parts used
Picramnia antidesma is a medicinal plant that has long been utilized in tropical areas of the Americas to treat malaria. Researchers have focused their investigations on the plant's root bark to identify its bioactive components. Through activity-guided studies of crude extracts, scientists isolated a new compound known as 10-epi-uveoside. This discovery occurred within a cytotoxic fraction that contained a rich mixture of anthrone glycosides. Ultimately, the high levels of cytotoxicity found in these anthraquinone derivatives suggest that infusions from the root may lack the selectivity required for effective antimalarial treatment.